Kechun Chen - Publications

OAC1 improves mitofusin 2 expression to alleviate neuronal injury following experimental ischemic stroke.

Journal: The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology

Published: December 28, 2024

TDP43 augments astrocyte inflammatory activity through mtDNA-cGAS-STING axis in NMOSD.

Journal: Journal of neuroinflammation

Published: October 14, 2024

Harnessing patient-derived antibodies-induced microglial complement 1q expression: Novel therapy for anti-NMDAR encephalitis.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: September 30, 2024

Inhibition of Phosphodiesterase 4 Suppresses Neuronal Ferroptosis After Cerebral Ischemia/Reperfusion.

Journal: Molecular neurobiology

Published: March 10, 2024

Mitofusin 2 Mediates the Protective Effect of NR6A1 Silencing Against Neuronal Injury in Experimental Stroke Models.

Journal: Molecular neurobiology

Published: February 17, 2024

Involvement of CKS1B in the anti-inflammatory effects of cannabidiol in experimental stroke models.

Journal: Experimental neurology

Published: September 25, 2023

Inhibition of phosphodiesterase 4 attenuates aquaporin 4 expression and astrocyte swelling following cerebral ischemia/reperfusion injury.

Journal: Glia

Published: August 02, 2023

Roflumilast, a cyclic nucleotide phosphodiesterase 4 inhibitor, protects against cerebrovascular endothelial injury following cerebral ischemia/reperfusion by activating the Notch1/Hes1 pathway.

Journal: European journal of pharmacology

Published: March 02, 2022

Mitofusin 2 confers the suppression of microglial activation by cannabidiol: Insights from in vitro and in vivo models.

Journal: Brain, behavior, and immunity

Published: February 21, 2022